InvestorsHub Logo
Followers 74
Posts 16404
Boards Moderated 3
Alias Born 04/24/2000

Re: Pan_O_War post# 74

Thursday, 05/06/2021 8:14:22 AM

Thursday, May 06, 2021 8:14:22 AM

Post# of 326
Clive's forte does seem to embrace biopharma marketing. From his LinkedIn vitae:

Mr. Bertram is the Head of Corporate Development at Petra Pharma. He joined Sangart in December 2008. He brings over 15 years of strategic marketing and sales experience in both international and local markets.

Prior to Sangart he has held senior strategic marketing positions in a number of pharmaceutical and biopharmaceutical companies. These include Senior Director of International Marketing at Pharmion, European Marketing Director at Chiron Biopharmaceuticals, Global Commercial Development at Celltech, as well as several Sales & Marketing positions at Eli Lilly and Company.

He is an experienced leader across many functions and countries with a specific focus on development and implementation of strategic and operational plans from early disease strategy through development and launch to established brands.


My only other comment (concern) is why, when the company is gearing up for what appears to be a productive transformative year, the previous CCO bails? Seems to me they could've been a little more forthcoming with the reasons other than the boilerplate response that "he is pursuing other opportunities". At least tell us whether or not he left of his own accord or you pushed him out because he sucks...

Theo ;-)